do-me/EUR-LEX huggingface dataset:
Appointment of a Hearing Officer in certain competition proceedings 2021/C 463 I/01
Date: 2021-11-16
Institutions: Directorate-General for Human Resources and Security, European Commission
Subjects: European official, administrative procedure, appointment of members, competition law








CI2021463EN.01000101.xml










16.11.2021   


EN


Official Journal of the European Union


CI 463/1






Appointment of a Hearing Officer in certain competition proceedings
(2021/C 463 I/01)
Following the transfer of Mr Wouter WILS, the Commission has appointed Mr Eric GIPPINI FOURNIER to the post of Hearing Officer with effect as from 1 December 2021, in accordance with the Decision of the President of the European Commission of 13 October 2011 on the function and terms of reference of the hearing officer in certain competition proceedings (OJ L 275, 20.10.2011, p. 29).
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (OJ L 396, 30.12.2006 , p. 1.)) (Text with EEA relevance) 2021/C 463/10
Date: 2021-11-16
Institutions: Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, European Commission
Subjects: chemical compound, chemical product, health control, health risk, market approval, marketing standard, pharmaceutical industry, solvent








C_2021463EN.01001101.xml










16.11.2021   


EN


Official Journal of the European Union


C 463/11






Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)


(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (1))

(Text with EEA relevance)
(2021/C 463/10)

Decision granting an authorisation













Reference of the decision (2)



Date of decision


Substance name


Holder of the authorisation


Authorisation number


Authorised use


Date of expiry
of review period


Reasons for the decision




C(2021)7882


9 November 2021


4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated
(4-tert-OPnEO)
EC No: -, CAS No:-


Novo Nordisk A/S, Novo Alle, 2880 Bagsværd, Denmark


REACH/21/11/0


As a solvent/detergent agent for virus inactivation in the manufacture of pharmaceutical products used in the treatment of rare bleeding disorders


4 January 2033


In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health from the uses of the substance and there are no suitable alternative substances or technologies.






(1)  OJ L 396, 30.12.2006 , p. 1.

(2)  The decision is available on the European Commission website at: Authorisation (europa.eu)
Case T-491/19: Order of the General Court of 16 November 2021 — Vodafone Group and Others v Commission
Date: 2021-11-16
Institutions: General Court
Subjects: State aid, United Kingdom, control of State aid, corporation tax, equal treatment, foreign enterprise, group of companies, right of establishment, tax avoidance, tax exemption








C_2022024EN.01004901.xml










17.1.2022   


EN


Official Journal of the European Union


C 24/49






Order of the General Court of 16 November 2021 — Vodafone Group and Others v Commission
(Case T-491/19) (1)

(2022/C 24/64)
Language of the case: English
The President of the Tenth Chamber has ordered that the case be removed from the register.


(1)  OJ C 312, 16.9.2019.
Non-opposition to a notified concentration (Case 10468 – NREP / NOVO HOLDINGS / INDUSTRIENS PENSIONSFORSIKRING / JV) (Text with EEA relevance) 2021/C 472/01
Date: 2021-11-16
Institutions: Directorate-General for Competition, European Commission
Subjects: economic concentration, holding company, investment company, joint venture, life sciences, merger control, pension scheme, real estate business








C_2021472EN.01000101.xml










23.11.2021   


EN


Official Journal of the European Union


C 472/1






Non-opposition to a notified concentration
(Case 10468 – NREP / NOVO HOLDINGS / INDUSTRIENS PENSIONSFORSIKRING / JV)
(Text with EEA relevance)
(2021/C 472/01)
On 16 November 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:






—


in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,










—


in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10468. EUR-Lex is the online point of access to European Union law.






(1)  OJ L 24, 29.1.2004, p. 1.
Euro exchange rates (Source: reference exchange rate published by the ECB.) 15 November 2021 2021/C 463/09
Date: 2021-11-16
Institutions: European Commission
Subjects: euro, exchange rate, money








C_2021463EN.01001001.xml










16.11.2021   


EN


Official Journal of the European Union


C 463/10






Euro exchange rates (1)

15 November 2021
(2021/C 463/09)

1 euro =











 


Currency


Exchange rate




USD


US dollar


1,1444 




JPY


Japanese yen


130,32 




DKK


Danish krone


7,4375 




GBP


Pound sterling


0,85165 




SEK


Swedish krona


10,0070 




CHF


Swiss franc


1,0533 




ISK


Iceland króna


150,40 




NOK


Norwegian krone


9,9173 




BGN


Bulgarian lev


1,9558 




CZK


Czech koruna


25,217 




HUF


Hungarian forint


365,98 




PLN


Polish zloty


4,6374 




RON


Romanian leu


4,9496 




TRY


Turkish lira


11,4643 




AUD


Australian dollar


1,5537 




CAD


Canadian dollar


1,4334 




HKD


Hong Kong dollar


8,9156 




NZD


New Zealand dollar


1,6174 




SGD


Singapore dollar


1,5457 




KRW


South Korean won


1 350,36 




ZAR


South African rand


17,3545 




CNY


Chinese yuan renminbi


7,3034 




HRK


Croatian kuna


7,5128 




IDR


Indonesian rupiah


16 225,69 




MYR


Malaysian ringgit


4,7624 




PHP


Philippine peso


57,309 




RUB


Russian rouble


82,8109 




THB


Thai baht


37,428 




BRL


Brazilian real


6,2458 




MXN


Mexican peso


23,5097 




INR


Indian rupee


85,1430 






(1)  Source: reference exchange rate published by the ECB.
Prior notification of a concentration (Case M.10503 – SK Capital Partners / Seqens) (Text with EEA relevance) 2021/C 463/19
Date: 2021-11-16
Institutions: Directorate-General for Competition, European Commission
Subjects: chemical industry, economic concentration, investment company, merger control, pharmaceutical industry, special chemicals








C_2021463EN.01002201.xml










16.11.2021   


EN


Official Journal of the European Union


C 463/22






Prior notification of a concentration
(Case M.10503 – SK Capital Partners / Seqens)
(Text with EEA relevance)
(2021/C 463/19)

1.   
On 8 November 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).
This notification concerns the following undertakings:






—


SK Capital Partners, LP (‘SK Capital Partners’, US),










—


Seqens Group Holding SAS (‘Seqens’, France).




SK Capital Partners acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of Seqens.
The concentration is accomplished by way of purchase of shares.


2.   
The business activities of the undertakings concerned are:






—


SK Capital Partners is a private investment firm focused on specialty materials, chemicals and the pharmaceutical sector;










—


Seqens is active in the manufacturing and distribution of diversified essential chemicals, pharmaceutical solutions and specialty ingredients.






3.   

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.



4.   
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.10503 – SK Capital Partners / Seqens
Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:
Email: COMP-MERGER-REGISTRY@ec.europa.eu
Fax +32 22964301
Postal address:





European Commission




Directorate-General for Competition




Merger Registry




1049 Bruxelles/Brussel




BELGIQUE/BELGIË







(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Case C-689/21: Request for a preliminary ruling from the Østre Landsret (Denmark) lodged on 16 November 2021 — X v Udlændinge- og Integrationsministeriet
Date: 2021-11-16
Institutions: Court of Justice
Subjects: EU Member State, European citizenship, equal treatment, nationality, protection of privacy, residence








C_2022064EN.01001701.xml










7.2.2022   


EN


Official Journal of the European Union


C 64/17






Request for a preliminary ruling from the Østre Landsret (Denmark) lodged on 16 November 2021 — X v Udlændinge- og Integrationsministeriet
(Case C-689/21)
(2022/C 64/27)
Language of the case: Danish

Referring court

Østre Landsret

Parties to the main proceedings


Applicant: X

Defendant: Udlændinge- og Integrationsministeriet

Questions referred







1.


Does Article 20 TFEU, in conjunction with Article 7 [of the Charter], preclude legislation of a Member State, such as that at issue in the main proceedings, under which citizenship of that Member State is, in principle, lost by operation of law on reaching the age of 22 in the case of persons born outside that Member State who have never lived in that Member State and who have also not resided there in circumstances that indicate a close attachment to that Member State, with the result that persons who do not also have citizenship of another Member State are deprived of their status as Union citizens and of the rights attaching to that status, taking into account that it follows from the legislation at issue in the main proceedings that:






(a)


a close attachment to the Member State is presumed to exist, in particular, after a total of one year’s residence in that Member State,










(b)


if an application to retain citizenship is submitted before the person reaches the age of 22, authorisation to retain citizenship of the Member State under less stringent conditions may be obtained and for that purpose the competent authorities must examine the consequences of loss of citizenship, and










(c)


lost citizenship can be recovered after the person concerned reaches the age of 22 only by means of naturalisation, to which a number of requirements are attached, including that of uninterrupted residence in the Member State for a longer duration, although the period of residence may be somewhat shortened for former nationals of that Member State?